CHF Solutions, Inc (CHFS)

[Eurotradr]

CHF Solutions Further Expands Commercial Presence in the Middle East with Distribution Arrangement for Israel and Palestine - https://www.bloomberg.com/press-releases/2020-07-30/chf-solutions-further-expands-commercial-presence-in-the-middle-east-with-distribution-arrangement-for-israel-and-palestine

CHF Solutions Further Expands Commercial Presence in the Middle East with
Distribution Arrangement for Israel and Palestine

EDEN PRAIRIE, Minn., July 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq:
CHFS) today announced the signing of a distribution agreement with SysteMedic
Ltd., covering Israel and Palestine, representing the second distribution
partnership in the Middle East region. Ultrafiltration therapy is now
available in 16 countries outside the U.S.

Ninety percent of hospitalizations among heart failure patients are due to
signs and symptoms of fluid overload,^1 and approximately two percent of the
Israeli population suffers from heart failure.^2 The Aquadex SmartFlow System
is a simple, flexible and smart fluid management platform using
ultrafiltration to stabilize patients experiencing fluid overload, giving
providers the ability to manage their patients’ fluid balance with precision,
control and ease.

“CHF Solutions is committed to making ultrafiltration therapy available for
patients throughout the world. Our partnership with SysteMedic demonstrates
continued execution on that strategy,” said John Erb, chairman and CEO of CHF
Solutions. “Subject to regulatory approval, we look forward to working with
SysteMedic to make the simple, flexible and smart Aquadex SmartFlow™ system
available to patients in Israel and Palestine suffering from fluid overload
due to heart failure, cardiovascular surgery and other critical care
conditions.”

“We are very excited to work with CHF Solutions to introduce their
ultrafiltration technology to Israel and Palestine,” said Arik Yanco, General
Manager of SysteMedic. “We believe the Aquadex therapy will make a difference
in the quality of lives of patients and look forward to a successful
partnership.”

^1 Costanzo MR et al. JACC. 2017;69(19):2428-45.
^2 www.health.gov.il/PublicationsFiles/health2013.pdf.